Violeta Rus

3.0k total citations
79 papers, 2.4k citations indexed

About

Violeta Rus is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Violeta Rus has authored 79 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 22 papers in Rheumatology and 18 papers in Molecular Biology. Recurrent topics in Violeta Rus's work include Systemic Lupus Erythematosus Research (21 papers), Multiple Sclerosis Research Studies (11 papers) and Complement system in diseases (11 papers). Violeta Rus is often cited by papers focused on Systemic Lupus Erythematosus Research (21 papers), Multiple Sclerosis Research Studies (11 papers) and Complement system in diseases (11 papers). Violeta Rus collaborates with scholars based in United States, Romania and India. Violeta Rus's co-authors include Horea Rus, Charles S. Via, Florin Niculescu, Cornelia Cudrici, Cosmin Tegla, William C. Gause, Matthew Fosbrink, Sonia I. Vlaicu, Moon L. Shin and Alexandru Tatomir and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and International Journal of Molecular Sciences.

In The Last Decade

Violeta Rus

76 papers receiving 2.3k citations

Peers

Countries citing papers authored by Violeta Rus

Since Specialization

Citations

This map shows the geographic impact of Violeta Rus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Rus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Rus more than expected).

Fields of papers citing papers by Violeta Rus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violeta Rus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Rus. The network helps show where Violeta Rus may publish in the future.

Co-authorship network of co-authors of Violeta Rus

This figure shows the co-authorship network connecting the top 25 collaborators of Violeta Rus. A scholar is included among the top collaborators of Violeta Rus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Violeta Rus. Violeta Rus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial 2024 ·Lupus Science & Medicine ·Jane E. Salmon, Daniel J. Wallace, Violeta Rus, (unknown), (unknown), (unknown), Yunpeng Ding, Petter‐Arnt Hals, Line Johnsen, Peter E. Lipsky	3
2	RGC-32 mediates proinflammatory and profibrotic pathways in immune-mediated kidney disease 2024 ·Clinical Immunology ·Alexandru Tatomir, Sonia I. Vlaicu, Vinh Nguyen, Irina G. Luzina, Sergei P. Atamas, Cinthia Drachenberg, John C. Papadimitriou, Tudor C. Badea, Horea Rus, Violeta Rus	0
3	COVID, complement, and the brain 2023 ·Frontiers in Immunology ·Sonia I. Vlaicu, Alexandru Tatomir, (unknown), Violeta Rus, Horea Rus	11
4	Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects Against Pulmonary Fibrosis 2021 ·American Journal of Respiratory Cell and Molecular Biology ·Irina G. Luzina, Violeta Rus, Virginia Lockatell, (unknown), Brian Hampton, Rita Fishelevich, Alexander V. Misharin, Nevins W. Todd, Tudor C. Badea, Horea Rus, Sergei P. Atamas	12
5	Role of C5b-9 and RGC-32 in Cancer 2019 ·Frontiers in Immunology ·Sonia I. Vlaicu, Alexandru Tatomir, Violeta Rus, Horea Rus	22
6	RGC-32 regulates reactive astrocytosis and extracellular matrix deposition in experimental autoimmune encephalomyelitis 2018 ·Immunologic Research ·Alexandru Tatomir, Cosmin Tegla, (unknown), Dallas Boodhoo, Vinh Nguyen, (unknown), (unknown), (unknown), (unknown), Cornelia Cudrici, Tudor C. Badea, Violeta Rus, Horea Rus	17
7	Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer 2012 ·Immunologic Research ·Sonia I. Vlaicu, Cosmin Tegla, Cornelia Cudrici, (unknown), Hassan Madani, (unknown), Florin Niculescu, Petru Adrian Mircea, Violeta Rus, Horea Rus	36
8	Membrane attack by complement: the assembly and biology of terminal complement complexes 2011 ·Immunologic Research ·Cosmin Tegla, Cornelia Cudrici, Snehal Patel, (unknown), Violeta Rus, Florin Niculescu, Horea Rus	213
9	Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells 2009 ·Experimental and Molecular Pathology ·Matthew Fosbrink, Cornelia Cudrici, Cosmin Tegla, (unknown), Takahiro Ito, Sonia I. Vlaicu, Violeta Rus, Florin Niculescu, Horea Rus	58
10	THE RELATION BETWEEN COGGINS TEST AND ELISA IN THE DIAGNOSIS OF EQUINE INFECTIOUS ANEMIA 2008 ·Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca Veterinary Medicine ·Pompei Bolfă, (unknown), (unknown), Marian Taulescu, A. Gal, Violeta Rus, (unknown)	3
11	CELL MEDIATED IMMUNE CHANGES IN EQUINE INFECTIOUS ANEMIA 2008 ·Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca Veterinary Medicine ·Pompei Bolfă, (unknown), (unknown), Marian Taulescu, (unknown), Violeta Rus	1
12	Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis 2008 ·Journal of Neuroimmunology ·Cornelia Cudrici, Takahiro Ito, (unknown), Susanna H. Weerth, Violeta Rus, Hegang Chen, Florin Niculescu, (unknown), Cosmin Tegla, Adrian Gherman, Cedric S. Raine, Moon L. Shin, Horea Rus	18
13	T Cell TRAIL Promotes Murine Lupus by Sustaining Effector CD4 Th Cell Numbers and by Inhibiting CD8 CTL Activity 2007 ·The Journal of Immunology ·Violeta Rus, Vinh Nguyen, Roman Puliaev, (unknown), Valentina Zernetkina, Irina G. Luzina, John C. Papadimitriou, Charles S. Via	32
14	C5b-9 Terminal Complex Protects Oligodendrocytes from Apoptotic Cell Death by Inhibiting Caspase-8 Processing and Up-Regulating FLIP 2006 ·The Journal of Immunology ·Cornelia Cudrici, Florin Niculescu, (unknown), (unknown), Matthew Fosbrink, Violeta Rus, Moon L. Shin, Horea Rus	51
15	Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease 2005 ·Clinical Immunology ·Violeta Rus, Valentina Zernetkina, Roman Puliaev, Cornelia Cudrici, Susan Mathai, Charles S. Via	28
16	Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease 2004 ·Clinical Immunology ·Violeta Rus, Hegang Chen, Valentina Zernetkina, Laurence S. Magder, Susan Mathai, Marc C. Hochberg, Charles S. Via	34
17	Pathogenic T cells in murine lupus exhibit spontaneous signaling activity through phosphatidylinositol 3‐kinase and mitogen‐activated protein kinase pathways 2003 ·Arthritis & Rheumatism ·Florin Niculescu, Phuong Nguyen, Teodora Niculescu, Horea Rus, Violeta Rus, Charles S. Via	24
18	In Vivo Neutralization of TNF-α Promotes Humoral Autoimmunity by Preventing the Induction of CTL 2001 ·The Journal of Immunology ·Charles S. Via, Andrei R. Shustov, Violeta Rus, Thomas Lang, Phuong Nguyen, Fred D. Finkelman	124
19	Clinical value of antineutrophil cytoplasmic antibodies 2000 ·Current Rheumatology Reports ·Violeta Rus, Barry S. Handwerger	2
20	The role of cytokines in the immunopathogenesis of lupus 1994 ·Springer Seminars in Immunopathology ·Barry S. Handwerger, Violeta Rus, (unknown), Charles S. Via	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact